黒色腫の疫学的予測（～2023）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Related Reports 9
2.3 Upcoming Related Reports 9
3 Epidemiology 10
3.1 Disease Background 10
3.2 Risk Factors and Comorbidities 11
3.3 Global Trends 13
3.3.1 US 14
3.3.2 5EU 14
3.3.3 Japan and Australia 14
3.4 Forecast Methodology 15
3.4.1 Sources Used 17
3.4.2 Sources Not Used 22
3.4.3 Forecast Assumptions and Methods 22
3.5 Epidemiological Forecast for Melanoma (2013-2023) 26
3.5.1 Diagnosed Incident Cases of Melanoma 26
3.5.2 Age-Specific Diagnosed Incident Cases of Melanoma 27
3.5.3 Sex-Specific Diagnosed Incident Cases of Melanoma Skin Cancer 29
3.5.4 Age-Standardized Diagnosed Incidence Rates 31
3.5.5 Pathological Stage at Diagnosis 33
3.5.6 Five-Year Diagnosed Prevalent Cases of Melanoma Skin Cancer 34
3.5.7 Five-Year Diagnosed Prevalent Cases of Melanoma Skin Cancer by Genetic Aberrations 36
3.6 Discussion 38
3.6.1 Epidemiological Forecast Insight 38
3.6.2 Limitations of the Analysis 39
3.6.3 Strengths of the Analysis 40
4 Appendix 41
4.1 Bibliography 41
4.2 About the Authors 46
4.2.1 Epidemiologists 46
4.2.2 Reviewers 46
4.2.3 Global Director of Therapy Analysis and Epidemiology 48
4.2.4 Global Head of Healthcare 48
4.3 About GlobalData 49
4.4 About EpiCast 49
4.5 Disclaimer 50